Nair Sanjeev V, Balasubramanian Karthikeyan, Ramasamy Ashok, Thamizhselvam Haripriya, Gharia Shivangi, Periasamy Soundararajan
Department of Nephrology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
Dialysis Technology, Department of Nephrology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
Hemodial Int. 2021 Mar 18. doi: 10.1111/hdi.12921.
High dialysate sodium is a significant contributor to intradialytic hypertension (IDH) in maintenance hemodialysis patients. In this study, we aimed to study the effect of low dialysate sodium on IDH in Indian hemodialysis patients.
Fifty patients on maintenance hemodialysis for atleast 3 months with episodes of IDH were enrolled in this study. The study was performed in two different stages. In the first phase, patients were dialyzed with standard dialysate sodium (140 mEq/L) for eight consecutive sessions and in the second phase, they were dialyzed with low sodium dialysate (136 mEq/L) for eight consecutive sessions. Differences in pre, intradialytic, and post-HD blood pressure, interdialytic weight gain, mean serum sodium, intradialytic adverse events, and number of IDH episodes requiring intervention between the two phases were assessed.
The mean age of the study population was 52 years (36 males,14 females). The mean post-HD systolic and diastolic BP was 163.26 ± 9.58 mmHg and 88.60 ± 5.27 mmHg in the standard dialysate phase and 142.38 ± 14.09 mmHg and 84.58 ± 4.276 mmHg, respectively, in the low dialysate phase (p < 0.01). Interdialytic weight gain was 3.34 ± 0.9 and 3.11 ± 0.86 in the standard and low sodium dialysate phases, respectively (p = 0.19).The mean pre-HD plasma sodium level was 138.48 ± 3.69 and 135.80 ± 1.35 mEq/dl, respectively, in standard and low dialysate phases (p = 0.01). There was significant reduction in number of IDH episodes requiring intervention. There was no difference in hypotensive episodes, adverse events between the two phases.
In patients with intradialytic hypertension, low dialysate sodium significantly reduces the post-HD blood pressure and intradialytic hypertensive episodes, when compared with standard sodium dialysate.
高透析液钠是维持性血液透析患者透析中高血压(IDH)的重要促成因素。在本研究中,我们旨在研究低透析液钠对印度血液透析患者IDH的影响。
本研究纳入了50例维持性血液透析至少3个月且有IDH发作的患者。该研究分两个不同阶段进行。在第一阶段,患者连续8次使用标准透析液钠(140mEq/L)进行透析,在第二阶段,他们连续8次使用低钠透析液(136mEq/L)进行透析。评估两个阶段之间透析前、透析中和透析后血压、透析间期体重增加、平均血清钠、透析中不良事件以及需要干预的IDH发作次数的差异。
研究人群的平均年龄为52岁(男性36例,女性14例)。在标准透析液阶段,透析后平均收缩压和舒张压分别为163.26±9.58mmHg和88.60±5.27mmHg,在低透析液阶段分别为142.38±14.09mmHg和84.58±4.276mmHg(p<0.01)。透析间期体重增加在标准和低钠透析液阶段分别为3.34±0.9和3.11±0.86(p = 0.19)。透析前血浆钠平均水平在标准和低透析液阶段分别为138.48±3.69和135.80±1.35mEq/dl(p = 0.01)。需要干预的IDH发作次数显著减少。两个阶段之间的低血压发作、不良事件无差异。
与标准钠透析液相比,在透析中高血压患者中,低透析液钠可显著降低透析后血压和透析中高血压发作次数。